Literature DB >> 10447606

Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factors.

H J Yang1, D H Nam, K C Wang, Y M Kim, J G Chi, B K Cho.   

Abstract

To investigate clinical features, treatment outcome and prognostic factors of pediatric supratentorial primitive neuroectodermal tumors(ST-PNETs), 28 ST-PNET cases were retrospectively analyzed. The prognostic importance of age, sex, size of tumor, M stage, extent of surgical resection, histological features, immunohistochemical labelling indices (Ki-67, p53), and apoptotic index were assessed. The mean age at diagnosis was 6.8 years, and the male-to-female ratio was 18:10. The presenting symptoms in 22 cases were increased intracranial pressure and focal neurological deficits. Gross total resection was achieved in 17 cases, near-total (>90%) resection in 3, and subtotal in 7; biopsy was performed in 1 case. The mean duration of follow-up was 37 months. For 25 patients who completed planned adjuvant therapy, the 3-year survival rate was 73%. Univariate analysis showed that the presence of tumor necrosis (P=0.002) and extent of resection (P=0.04) correlated with survival. Patients with a high Ki-67 labelling index (>10%) tended to have shorter survival (P=0.095). In multivariate analysis, tumor necrosis showed statistical significance(P=0.03).

Entities:  

Mesh:

Year:  1999        PMID: 10447606     DOI: 10.1007/s003810050418

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  8 in total

1.  Supratentorial primitive neuroectodermal tumors in adults.

Authors:  Dong Gyu Kim; Dong Yeob Lee; Sun Ha Paek; Je G Chi; Gheeyoung Choe; Hee-Won Jung
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

2.  Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor.

Authors:  Rachael A Lester; Lindsay C Brown; Laurence J Eckel; Robert T Foote; Amulya A NageswaraRao; Jan C Buckner; Ian F Parney; Nicholas M Wetjen; Nadia N Laack
Journal:  J Neurooncol       Date:  2014-08-13       Impact factor: 4.130

Review 3.  Is there a role for high dose chemotherapy with hematopoietic stem cell rescue in patients with relapsed supratentorial PNET?

Authors:  C P Raghuram; L Moreno; S Zacharoulis
Journal:  J Neurooncol       Date:  2011-08-18       Impact factor: 4.130

4.  Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome.

Authors:  Michel De Vos; Bruce E Hayward; Susan Picton; Eamonn Sheridan; David T Bonthron
Journal:  Am J Hum Genet       Date:  2004-04-07       Impact factor: 11.025

5.  The presenting features of brain tumours: a review of 200 cases.

Authors:  S H Wilne; R C Ferris; A Nathwani; C R Kennedy
Journal:  Arch Dis Child       Date:  2006-03-17       Impact factor: 3.791

6.  Supratentorial primitive neuroectodermal tumors: a Canadian pediatric brain tumor consortium report.

Authors:  Donna L Johnston; Daniel L Keene; Lucie Lafay-Cousin; Paul Steinbok; Lillian Sung; Anne-Sophie Carret; Bruce Crooks; Douglas Strother; Beverly Wilson; Isaac Odame; David D Eisenstat; Chris Mpofu; Shayna Zelcer; Annie Huang; Eric Bouffet
Journal:  J Neurooncol       Date:  2007-07-10       Impact factor: 4.130

Review 7.  A supratentorial primitive neuroectodermal tumor in an adult: a case report and review of the literature.

Authors:  Shigeo Ohba; Kazunari Yoshida; Yuichi Hirose; Eiji Ikeda; Takeshi Kawase
Journal:  J Neurooncol       Date:  2007-08-23       Impact factor: 4.506

8.  Tackling a recurrent pinealoblastoma.

Authors:  Siddanna Palled; Sruthi Kalavagunta; Jaipal Beerappa Gowda; Kavita Umesh; Mahalaxmi Aal; Tanvir Pasha Chitraduraga Abdul Razack; Veerabhadre Gowda; Lokesh Viswanath
Journal:  Case Rep Oncol Med       Date:  2014-08-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.